「th」の検索結果
186件：171～175件目を表示
-
Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the marketing authorization of “Aibeta® Combin...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the marketing authorization of “Aibeta® Combin...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
6 年 1 月 29 日文部科学・環境省令第 1 号） 9) げっ歯類の胎児・新生児の鎮痛・麻酔および安楽死に関する声明（平成 27 年 11 月 11 日 第 2 版、日本実験動物医学会） 10) The Guide for the Care and Use of LaboratoryAnimals 8th edition. National Research Council, 2011. 11...
https://www.senju.co.jp/about/rp/regulations.pdf -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/rd/society/ -
学会发表 | 研究与开发 | 千寿制药株式会社
Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：...
https://www.senju.co.jp/chinese/rd/society/